ResMed Income Statement
RMD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
ResMed reported $5.1B in revenue and $1.4B in net income for FY2025. Revenue has grown at a 10.7% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1B | $4.7B | $4.2B | $3.6B | $3.2B | $3.0B | $2.6B | $2.3B | $2.1B | $1.8B | $1.7B | $1.6B | $1.5B | $1.4B | $1.2B |
| Cost of Revenue | $2.1B | $2.0B | $1.9B | $1.6B | $1.4B | $1.2B | $1.1B | $1.0B | $865.0M | $772.2M | $667.5M | $565.2M | $573.8M | $547.8M | $501.8M |
| Gross Profit | $3.1B | $2.7B | $2.4B | $2.0B | $1.8B | $1.7B | $1.5B | $1.3B | $1.2B | $1.1B | $1.0B | $989.8M | $940.7M | $820.7M | $741.3M |
| SG&A Expense | $991.0M | $917.1M | $874.0M | $737.5M | $670.4M | $676.7M | $645.0M | $600.4M | $554.0M | $488.1M | $478.6M | $450.4M | $430.8M | $402.6M | $372.2M |
| R&D Expense | $331.3M | $307.5M | $287.6M | $253.6M | $225.3M | $201.9M | $180.7M | $155.1M | $144.5M | $118.7M | $114.9M | $118.2M | $120.1M | $109.7M | $92.0M |
| Operating Income | $1.7B | $1.3B | $1.1B | $1.0B | $903.7M | $809.7M | $579.3M | $541.8M | $425.8M | $429.0M | $409.2M | $405.1M | $354.8M | $294.4M | $266.9M |
| Interest Expense | - | - | - | - | $24.0M | $40.4M | $36.2M | $28.4M | $28.2M | $11.2M | $5.8M | $6.1M | $6.4M | $4.8M | $1.8M |
| Income Tax | $276.8M | $243.8M | $204.1M | $181.0M | $409.2M | $111.4M | $114.3M | $205.7M | $76.5M | $87.2M | $83.0M | $85.8M | $78.0M | $77.1M | $76.7M |
| Net Income | $1.4B | $1.0B | $897.6M | $779.4M | $474.5M | $621.7M | $404.6M | $315.6M | $342.3M | $352.4M | $352.9M | $345.3M | $307.1M | $254.8M | $227.0M |
| EPS (Basic) | $6.12 | $5.34 | $3.27 | $4.31 | $2.83 | $2.21 | $2.42 | $2.51 | $2.51 | $2.44 | $2.15 | $1.75 | $1.49 | $1.26 | $0.97 |
| EPS (Diluted) | $6.09 | $5.30 | $3.24 | $4.27 | $2.80 | $2.19 | $2.40 | $2.49 | $2.47 | $2.39 | $2.10 | $1.71 | $1.44 | $1.23 | $0.95 |
| Shares Outstanding | 146.9M | 147.1M | 146.4M | 145.6M | 144.9M | 143.7M | 142.7M | 142.2M | 140.7M | 140.5M | 140.3M | 142.0M | 142.0M | 151.7M | 151.3M |
| Gross Margin | 59.4% | 56.7% | 55.8% | 56.6% | 57.5% | 58.1% | 57.3% | 57.0% | 58.1% | 58.0% | 60.2% | 63.6% | 62.1% | 60.0% | 59.6% |
| Operating Margin | 32.8% | 28.2% | 26.8% | 28.0% | 28.3% | 27.4% | 22.2% | 23.2% | 20.6% | 23.3% | 24.4% | 26.1% | 23.4% | 21.5% | 21.5% |
| Profit Margin | 27.2% | 21.8% | 21.3% | 21.8% | 14.8% | 21.0% | 15.5% | 13.5% | 16.6% | 19.2% | 21.0% | 22.2% | 20.3% | 18.6% | 18.3% |